Mansoor Bolideei

Dr. Mansoor Bolideei

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2026 in Clinical and Experimental Medicine
Verified
Journal Article
Open access
JAJamal Alshorman
Jamal Alshorman
MMMohammad Javad Mehran
Mohammad Javad Mehran
YBYadollah Bahrami
Yadollah Bahrami
SMSara Mohammadzadeh
Sara Mohammadzadeh
RBRambod Barzigar
Rambod Barzigar
永王永平 王
永平 王
Artificial intelligence (AI) is increasingly advancing precision immunotherapy by integrating high-dimensional biomedical data to support diagnosis, treatment selection, and longitudinal monitoring in both cancer and autoimmune diseases. This review summarizes AI applications in biomarker discovery, prediction of immune checkpoint inhibitor (ICI) response and toxicity, neoantigen prioritization, CAR-T cell optimization, and therapeutic antibody engineering. In oncology, multimodal models combining multi-omics, medical imaging, and clinical variables improve patient stratification and non-invasive response assessment, with several imaging- and pathology-based prediction tasks reporting clinically meaningful performance (frequently AUC ~ 0.70–0.95 across tumor types and endpoints). In autoimmune diseases, AI enables earlier diagnosis, molecular subtyping, treatment-response prediction, and real-time disease activity tracking using EHR, laboratory, imaging, and wearable data—supporting precision management in conditions such as rheumatoid arthritis and type 1 diabetes. Key challenges include data heterogeneity, model interpretability, and governance; however, explainable AI, federated learning, and digital twin frameworks offer practical routes toward trustworthy clinical translation. Overall, AI is emerging as a foundational technology for next-generation, patient-specific immunotherapy across oncology and autoimmune medicine. Graphical abstract Artificial intelligence enhances cancer and autoimmune disease immunotherapy through biomarker discovery, response prediction, neoantigen and antibody optimization, and real-time treatment management, enabling precision medicine across clinical applications.

29 August 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
YBYadollah Bahrami
Yadollah Bahrami
MBMansoor Bolideei
Mansoor Bolideei
SMSara Mohammadzadeh
Sara Mohammadzadeh
RGRazieh Bahrami Gahrouei
Razieh Bahrami Gahrouei
EMElham Mohebbi
Elham Mohebbi
MMMohammad Javad Mehran
Mohammad Javad Mehran

15 June 2026 in Gene Therapy
Verified
Journal Article
Closed access
JAJamal Alshorman
Jamal Alshorman
MMMohammad Javad Mehran
Mohammad Javad Mehran
KTKingsley Miyanda Tembo
Kingsley Miyanda Tembo
NMNiusha Mostafavi
Niusha Mostafavi
MBMansoor Bolideei
Mansoor Bolideei
永王永平 王
永平 王